Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 173915011000036114 | agalsidase alfa (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 173916011000036119 | agalsidase alfa | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| agalsidase alfa | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| agalsidase alfa | has intended active ingredient | True | agalsidase alfa | Inferred relationship | Some | 1 |
| agalsidase alfa 3.5 mg/3.5 mL injection, vial | has intended active ingredient | True | agalsidase alfa | Inferred relationship | Some | 293702428 |
| agalsidase alfa 3.5 mg/3.5 mL injection, vial | has Australian BoSS | True | agalsidase alfa | Inferred relationship | Some | 293702428 |
| Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | has Australian BoSS | True | agalsidase alfa | Inferred relationship | Some | 2038872476 |
| Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | has intended active ingredient | True | agalsidase alfa | Inferred relationship | Some | 2038872476 |
This concept is not in any reference sets
FHIR